Turkey seeks 25 million COVID-19 vaccines from Pfizer
Turkey's Health Minister Fahrettin Koca said on Wednesday that the country will sign a contract to buy 1 million doses of a COVID-19 candidate vaccine from Pfizer and BioNTech by the year-end and 25 million more in 2021, state-run Anadolu news agency reported.
Koca said during a session at the Turkish parliament's planning and budget commission that the procurement will be made once the company obtained its license for the vaccine.
“If so, the number that can be given to Turkey is 1 million. We have talks right now to gradually go up to 25 million within the year starting from January,” Anadolu cited Koca as saying.
Pfizer and BioNTech may secure emergency U.S. and European authorisation for their vaccine next month after final trial results showed it had a 95 percent success rate and no serious side effects, the drugmakers said on Wednesday.
Turkey is in talks with China’s Sinovac Biotech for at least 20 million doses of the coronavirus vaccine, Koca said.
“We will be able to procure at least 10 million doses of the Chinese vaccine in December. We want to increase this number. It will be just as much in January, too,” he said.
Turkey's COVID-19 patients increased by 4,215 on Wednesday, raising the total number in the country to 425,628, according to Turkish Health Ministry's daily report.
A total of 116 people died in the past 24 hours, taking the death toll to 11,820.